Panel Discussion: Overcoming Safety Fears to Build Complex Gene-Edited Therapies
Time: 4:30 pm
day: Day 1: Pre-Clinical & Translational - Afternoon 2
- Comparing traditional gene editing strategies to CRISPR Cas9, Base editing etc
- How can we achieve a greater repertoire of gene edits in a safe manner?
- What are the downstream implications for manufacturing if you engage with complex gene editing?
- Exploring how to improve specificity of endo nucleases whilst balancing cargo size